Search

Home > Industry Focus > Healthcare: Are These Beaten-Down Clinical-Stage Biotechs Buys?
Podcast: Industry Focus
Episode:

Healthcare: Are These Beaten-Down Clinical-Stage Biotechs Buys?
Category: Business
Duration: 00:31:01
Publish Date: 2018-10-03 14:30:00
Description:

Geron shares tumbled after J&J jilted them and Omeros  shares fell sharply following a clinical-trial update. Should you avoid these stocks, or are they bargain bin stocks worth buying? GERN OMER INCY
Total Play: 0

Users also like

0 Episodes
MarketFooler .. 100+     6
700+ Episodes
Rule Breaker .. 200+     6
2K+ Episodes
Motley Fool .. 300+     10+

Some more Podcasts by The Motley Fool

300+ Episodes
Motley Fool ..    
700+ Episodes
Rule Breaker .. 200+     6
400+ Episodes
Motley Fool .. 100+     5
2K+ Episodes
Motley Fool .. 300+     10+
2K+ Episodes
Motley Fool ..